DR. LAWRENCE S. GOLDMAN MD. NPI 1609988211

NPI Details

DR. Lawrence S. Goldman, MD. is an internal medicine in Holbrook, NY with 42 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Lawrence S. Goldman, MD. NPI is 1609988211. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

203 UNION AVE
HOLBROOK, NY
ZIP 11741-704
Phone: (631) 585-5858
Fax: (631) 585-6362

The NPI 1609988211 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
• Urinalysis, manual test (HCPCS:81002)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Hemoglobin a1c level (HCPCS:83036)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Smoking and tobacco use intensive counseling, more than 10 minutes (HCPCS:99407)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Coronavirus vaccine 13 (HCPCS:91312)
• Coronavirus vaccine 14 (HCPCS:91313)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)

The enumeration date for this NPI number is 8/31/2006 and was last updated on 4/15/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.